nach oben

Erschienen in:

19.08.2021 | Original Article

Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a preliminary study quantifying the prevalence of Candida albicans in saliva

verfasst von: Ryuichiro Funahara, Sakiko Soutome, Madoka Funahara, Shoma Tsuda, Takumi Hasegawa, Masahiro Umeda, Masaya Akashi

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Serious oral mucositis develops during radiation therapy (RT) for head and neck cancer, but there is no effective preventive method. We have used a steroid ointment to prevent oral mucositis during RT, but the use of steroid ointment is discontinued when oral candidiasis develops. Therefore, prevention of oral candidiasis is important. The purpose of this study was to examine whether administration of a miconazole oral patch reduced the amount of Candida albicans in saliva and prevented the development of oral candidiasis during RT.

Methods

Participants were patients with head and neck cancer receiving RT ≥ 60 Gy. Patients in the intervention group received miconazole oral patches for 14 days after the appearance of grade 2 oral mucositis. The control group received oral care only. Total bacteria and C. albicans counts in the saliva were analyzed by real-time polymerase chain reaction. The incidence of oral candidiasis was compared between the groups.

Results

Total bacterial counts did not change throughout RT in either the intervention or the control group. However, C. albicans count significantly increased at 30 Gy and 60 Gy in the control group but was suppressed in the intervention group. The saliva pH did not show a significant change throughout RT in either group. The incidence of oral candidiasis in the intervention group tended to be lower than that in the control group.

Conclusion

This study suggested that prophylactic use of a miconazole oral patch was effective in suppressing the growth of C. albicans count in saliva during RT for head and neck cancer.

Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD (2020) Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18:873–898CrossRef

Marta GN, Silva V, de Andrade CH, de Arruda FF, Hanna SA, Gadia R, de Silva JLF, Correa SFM, Abreu CEC, Riera R (2014) Intensity–modulated radiation therapy for head and neck cancer: systematic review and meta–analysis. Radiother Oncol 110:9–15CrossRef

Rodríguez-Caballero A, Torres-Lagares D, Robles-García M, Pachón-Ibáñez J, González-Padilla D, Gutiérrez-Pérez JL (2012) Cancer treatment-induced oral mucositis: a critical review. Int J Oral Maxillofac Surg 41:225–238CrossRef

Moslemi D, Nokhandani AM, Otaghsaraei MT, Moghadamnia Y, Kazemi S, Moghadamnia AA (2016) Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: a review of the current literature. Radiother Oncol 120:13–20CrossRef

Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK (2017) Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial. Lancet Oncol 18:654–662CrossRef

Niikura N, Nakatukasa K, Amemiya T, Watanabe KI, Hata H, Kikawa Y, Taniike N, Yamanaka T, Mitsunaga S, Nakagami K, Adachi M, Kondo N, Shibuya Y, Hayashi N, Naito M, Kashiwabara K, Yamashita T, Umeda M, Mukai H, Ota Y (2020) Oral care evaluation to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (oral care-BC): a randomized controlled phase III trial. Oncologist 25:e223–e230CrossRef

Umeda M, Ota Y, Kashiwabara K, Hayashi N, Naito M, Yamashita T, Mukai H, Nakatsukasa K, Amemiya T, Watanabe K, Hata H, Kikawa Y, Taniike N, Yamanaka T, Mitsunaga S, Nakagami K, Adachi M, Kondo N, Shibuya y, Niikura N (2021) Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (oral care-BC). Ann Transl Med 9:535

Kawashita Y, Koyama Y, Kurita H, Otsuru M, Ota Y, Okura M, Horie A, Sekiya H, Umeda M (2019) Effectiveness of a comprehensive oral management protocol for the prevention of severe oral mucositis in patients receiving radiotherapy with or without chemotherapy for oral cancer: a multicentre, phase II, randomized controlled trial. Int J Oral Maxillofac Surg 48:857–864CrossRef

Kawashita Y, Funahara M, Yoshimatsu M, Nakao N, Soutome S, Saito T, Umeda M (2019) A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer: is topical steroid therapy a risk factor for oral candidiasis? Medicine (Baltimore) 97:e13073CrossRef

10.

Nishii M, Soutome S, Kawakita A, Yutori H, Iwata E, Akashi M, Hasegawa T, Kojima Y, Funahara M, Umeda M, Komori T (2020) Factors associated with severe oral mucositis and candidiasis in patients undergoing radiotherapy for oral and oropharyngeal carcinomas: a retrospective multicenter study of 326 patients. Support Care Cancer 28:1069–1075CrossRef

11.

Vazquez JA (2010) Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl) 2:89–101

12.

Epstein JB, Truelove EL, Hanson-Huggins K, Mancl LA, Chen A, Press OW, Petersdorf SH, Fritsche TR, Epstein JD (2004) Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy. Support Care Cancer 12(7):517–525CrossRef

13.

Vazquez JA, Sobel JD (2012) Miconazole mucoadhesive tablets: a novel delivery system. Clin Infect Dis 54:1480–1484CrossRef

14.

Takato T, Kitagawa Y, Kamikawa Y, Kishimoto H, Nakamura S, Komori T, Chikazu D, Mori Y, Tanzawa H, Katakura A, Kanekawa A, Umeda M, Gomi A, Yonenaga K (2021) A comparative randomized, open-label, multicenter study of the efficacy and safety of miconazole mucoadhesive tablets and miconazole gel in the treatment of oropharyngeal candidiasis. Med Mycol J 62:11–19CrossRef

15.

Common Terminology Criteria for Adverse Events (CTCAE) (2021) Version 5.0. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed at April 24

16.

Tsuda S, Soutome S, Hayashida S, Funahara M, Yanamoto S, Umeda M (2020) Topical povidone iodine inhibits bacterial growth in the oral cavity of patients on mechanical ventilation: a randomized controlled study. BMC Oral Health 20:62CrossRef

17.

Soutome S, Yanamoto S, Sumi M, Hayashida S, Kojima Y, Sawada S, Rokutanda S, Iwai H, Saito T, Umeda M (2021) Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery. J Bone Miner Metab 39:302–310CrossRef

18.

Withers HR, Taylor JM, Maciejewski B (1988) The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131–146CrossRef

19.

Tarnawski R, Fowler J, Skladowski K, Swierniak A, Suwiński R, Maciejewski B, Wygoda A (2002) How fast is repopulation of tumor cells during the treatment gap? Int J Radat Oncol Bio Phys 54:229–236CrossRef

20.

Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120:1453–1461CrossRef

21.

Yokota T, Tachibana H, Konishi T, Yurikusa T, Hamauchi S, Sakai K, Nishikawa M, Suzuki M, Naganawa Y, Hagihara T, Tsumaki H, Kubo T, Sato M, Taguri M, Morita S, Eguchi T, Kubota K, Zenda S (2016) Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy. Support Care Cancer 24:3029–3036PubMed

22.

Lalla RV, Brennan MT, Gordon SM, Sonis ST, Rosenthal DI, Keefe DM (2019) Oral mucositis due to high-dose chemotherapy and/or head and neck radiation therapy. J Natl Inst Monogr 53:lgz011

23.

Deng Z, Kiyuna A, Hasegawa M, Nakasone I, Hosokawa A, Suzuki M (2010) Oral candidiasis in patients receiving radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg 143:242–247CrossRef

24.

Ramirez-Anador V, Silverman S Jr, Mayer P, Tyler M, Quivery J (1997) Candical colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pahol Oral Radiol Endod 84:149–153CrossRef

25.

Quindós G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N, Eraso E (2019) Therapeutic tools for oral candidiasis: current and new antifungal drugs. Med Oral Patol Oral Cir Bucal 24:e172–e180PubMedPubMedCentral

26.

Zhang LW, Fu JY, Hua H, Yan ZM (2016) Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis. Oral Dis 22:185–195CrossRef

27.

Bensadoun RJ, Daoud J, El Gueddari B, Bastit L, Gourmet R, Rosikon A, Allavena C, Céruse P, Calais G, Attali P (2008) Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer. Cancer 112:204–211CrossRef

28.

Azirrawani A, Heidari E, Burke M, Fenlon MR, Banerjee A (2018) The effect of radiotherapy for treatment of head and neck cancer on oral flora and saliva. Oral Health Prev Dent 16:425–429

Titel: Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a preliminary study quantifying the prevalence of Candida albicans in saliva
verfasst von: Ryuichiro Funahara
Sakiko Soutome
Madoka Funahara
Shoma Tsuda
Takumi Hasegawa
Masahiro Umeda
Masaya Akashi
Publikationsdatum: 19.08.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06480-7

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Effects of a miconazole oral patch on preventing development of oral candidiasis in patients with head and neck cancer undergoing radiotherapy: results of a preliminary study quantifying the prevalence of Candida albicans in saliva